From Single Studies to Stronger Evidence: The Power of IPD Pooling
Transforming Fragmented Data into Robust, Actionable Evidence In clinical research and healthcare decision-making, a single study can provide valuable insights. However, relying on isolated data often leaves gaps. To build truly robust, credible, and actionable evidence, we must look at the bigger picture—combining and analyzing multiple studies together with the utmost scientific rigor. At Quinten […]
Quinten Health : the Evidence Operating System
Building Decision-Grade Evidence in Complex Clinical Contexts How Quinten Health supports clinical, regulatory, and access decisions with a patient-centric framework Why “complex contexts” require a different evidence strategy In many therapeutic areas, the evidence questions that matter most are also the hardest to answer. This is especially true for rare diseases, pediatric indications, and severe […]
An AI-powered tool to support the identification and selection of fit-for-use Real-World Data (RWD)
An AI-powered tool to support the identification and selection of fit-for-use Real-World Data (RWD) In the high-stakes environment of HTA and regulatory submissions, selecting the right Real-World Data (RWD) is no longer just a technical challenge—it is a race against time. To address this, Quinten Health is proud to showcase a breakthrough AI-driven methodology designed […]
Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real-World Data Sources for Fit-for-Purpose Studies
Publisher: Clinical Pharmacology and Therapeutics Authors: Sonia Zebachi, Julien Tanniou, Elisabeth Bakker, Sieta T. de Vries, Rossella Di Bidino, Entela Xoxi, Anna Glaser, Gianluigi Savarese, Jan Hillert, Peter G.M. Mol, Kelly Plueschke, Billy Amzal, Ghinwa Y. Hayek, Jeverson Moreira View publication Abstract The potential of real-world data (RWD), particularly from patient registries, has been increasingly recognized […]
Navigating the Real World: A Scoping Review of Structured Frameworks to Effectively Identify, Evaluate, and Select Real-World Data Sources for Fit-for-Purpose Studies
Event: EuroDURG 2025, Uppsala, Sweden Authors: Sonia Zebachi, Julien Tanniou, Elisabeth Bakker, Sieta T. de Vries, Rossella di Bidino, Entela Xoxi, Anna Glaser, Gianluigi Savarese, Jan Hillert, Peter G.M. Mol, Kelly Plueschke, Ghinwa Hayek, Billy Amzal, Jeverson Moreira View Poster The potential of real-world data (RWD), particularly from patient registries, has been increasingly recognised over […]
Les Grandes Tendances e-santé 2024
Explore the Future of digital health (E-santé): Engage with industry leaders at Station F in Paris and delve into the digital health world. Quinten Health is excited to attend the upcoming event, “Grandes Tendances de la E-santé 2024,” organized by Interaction Healthcare at Station F in Paris on January 30, 2024. This event will provide […]
Existing practices for the identification, selection or assessment of registries for regulatory/HTA purposes: a More-EUROPA project systematic review
Event: ISPOR Europe 2023, Copenhagen, Denmark Authors: S. Zebachi, J. Moreira, J. Tanniou, P. Godbillot, P. Tang, B. Amzal View Poster Objectives Real-world data (RWD), particularly patient registries, represent a potential useful source of information and may be required at various stages of the drug lifecycle. Different questions may be asked throughout the regulatory and/or […]
What are unmet needs in the use of registries in regulatory/HTA decision-making in Europe? A survey-based approach from the More-EUROPA project
Event: ISPOR Europe 2023, Copenhagen, Denmark Authors: J. Moreira, J. Tanniou, P. Tang, P. Godbillot, F. Ahrens, B. Amzal View Poster Objectives The More-EUROPA project, involving 14 public and private organizations from 7 EU countries, evaluates the effective and ethical use of registry data to support patient-centered decisions by drug regulators and Health Technology Assessment (HTA) agencies in Europe. Specifically, one […]
Quinten Health at BiotechX Europe 2023 for the second year running!
Quinten Health will be at BioTechX Europe in Basel, Switzerland. For the second year running, Quinten Health will be present at BioTechX! It’s an annual event organized by Terrapinn. It’s Europe’s largest congress covering diagnostics, precision medicine and digital transformation in pharmaceutical development and healthcare. Our management team, Billy Amzal (CEO), Alexandre Templier (President) and Frank Ahrens (CCO), will be accompanied […]
Machine learning algorithm identifies undiagnosed episodes of pertussis
Experts at Quinten Health have developed a supervised machine learning algorithm to identify undiagnosed episodes of pertussis in adolescents and adults reporting acute respiratory illness. As pertussis is often misidentified, misdiagnosed or misreported, it is complex to assess its incidence rate in the above-mentioned populations. The aim was therefore to better estimate the incidence in […]
